Fundación de investigación HM

Fundación de Investigación HM Hospitales (FiHM) is a leading Spanish non-profit research institution that manages the scientific and clinical research activities of the HM Hospitales group. The foundation serves as a critical bridge between basic research and clinical practice, operating specialized centers such as the Clara Campal Comprehensive Oncology Center (CIOCC) and the CIAC Cardiovascular Center. FiHM is particularly renowned for its Phase I Clinical Trials Unit, which is among the most active in Europe, facilitating early-access innovative therapies for patients. Its research infrastructure supports over 300 active clinical trials annually across diverse therapeutic areas including oncology, cardiology, and neuroscience. By maintaining strategic partnerships with global pharmaceutical companies and academic institutions, FiHM plays a pivotal role in advancing personalized medicine and translational research in Spain.